Osteoclast/NN
markers/NNS
accumulate/VBP
on/IN
cells/NNS
developing/VBG
from/IN
human/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
precursors/NNS
./.

Recent/JJ
studies/NNS
show/VBP
that/IN
human/JJ
osteoclasts/NNS
develop/VBP
in/FW
vitro/FW
from/IN
hematopoietic/JJ
cells/NNS
;/:
however/RB
,/,
special/JJ
cultures/NNS
conditions/NNS
and/or/CC
cytokine/NN
mobilized/VBN
peripheral/JJ
blood/NN
are/VBP
apparently/RB
required/VBN
./.
=====
Here/RB
,/,
we/PRP
report/VBP
that/IN
cells/NNS
expressing/VBG
osteoclast/NN
markers/NNS
differentiate/VBP
from/IN
precursors/NNS
present/JJ
in/IN
nonmobilized/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
(/(
PBMC/NN
)/)
,/,
without/IN
the/DT
addition/NN
of/IN
stromal/JJ
cells/NNS
,/,
growth/NN
factors/NNS
,/,
cytokines/NNS
or/CC
steroids/NNS
;/:
and/CC
characterize/VBP
their/PRP$
phenotype/NN
./.
=====
Three/CD
days/NNS
after/IN
establishing/VBG
high-density/JJ
PBMC/NN
cultures/NNS
(/(
1.5/CD
x/CC
10(6)/CD
cells/cm2/NNS
)/)
,/,
in/IN
serum-containing/JJ
medium/JJ
,/,
small/JJ
adherent/JJ
colonies/NNS
of/IN
tartrate/JJ
resistant/JJ
acid/NN
phosphatase/NN
positive/JJ
(/(
TRAP+/JJ
)/)
cells/NNS
emerge/VBP
,/,
amidst/IN
massive/JJ
monocyte/NN
cell/NN
death/NN
./.
=====
These/DT
adherent/JJ
cells/NNS
have/VBP
an/DT
eccentrically/RB
placed/JJ
,/,
round/JJ
nucleus/NN
,/,
and/CC
express/VB
low/JJ
levels/NNS
of/IN
TRAP/NN
and/CC
sodium/NN
fluoride-resistant- alpha-naphthyl-acetate-esterase/NN
(/(
NaF-R-NSE/NN
)/)
./.
=====
Over/IN
the/DT
next/JJ
week/NN
,/,
this/DT
cell/NN
population/NN
accumulates/VBZ
phenotypic/JJ
markers/NNS
of/IN
osteoclasts/NNS
(/(
vitronectin/NN
receptor/NN
[/(
VR/NN
]/)
,/,
calcitonin/NN
receptor/NN
,/,
TRAP/NN
,/,
cathepsin/NN
K/NN
protein/NN
,/,
and/CC
mRNA/NN
)/)
with/IN
increased/VBN
nuclearity/NN
,/,
covering/VBG
the/DT
entire/JJ
surface/NN
by/IN
15/CD
days/NNS
./.
=====
When/WRB
cultured/VBN
on/IN
bone/NN
,/,
VR+/JJ
,/,
TRAP+/JJ
cells/NNS
of/IN
low/JJ
multinuclearity/NN
appear/VBP
and/CC
cover/VBP
up/RB
to/TO
50/CD
%/NN
of/IN
the/DT
surface/NN
./.
=====
Resorption/NN
lacunae/NNS
can/MD
be/VB
observed/VBN
by/IN
day/NN
22/CD
./.
=====
Although/IN
these/DT
pits/NNS
are/VBP
not/RB
nearly/RB
as/IN
numerous/JJ
as/IN
the/DT
cells/NNS
of/IN
preosteoclast/JJ
phenotype/NN
,/,
they/PRP
do/VBP
represent/VB
the/DT
activity/NN
of/IN
a/DT
subset/NN
of/IN
osteoclast-like/JJ
cells/NNS
that/WDT
has/VBZ
achieved/VBN
osteoclastic/JJ
maturity/NN
under/IN
these/DT
culture/NN
conditions/NNS
./.
=====
Transcripts/NNS
for/IN
osteoprotegerin/NN
ligand/NN
(/(
OPGL/NN
)/)
,/,
an/DT
osteoclast/JJ
differentiation/NN
factor/NN
(/(
also/RB
known/VBN
as/IN
RANKL/NN
and/CC
TRANCE/NN
)/)
are/VBP
expressed/VBN
,/,
likely/RB
by/IN
adherent/JJ
cells/NNS
./.
=====
Thus/RB
,/,
an/DT
adherent/JJ
population/NN
of/IN
cells/NNS
,/,
with/IN
preosteoclast/osteoclast/JJ
phenotypic/JJ
properties/NNS
,/,
arises/VBZ
selectively/RB
under/IN
simple/JJ
culture/NN
conditions/NNS
from/IN
normal/JJ
PBMC/NN
./.
=====
Further/JJ
characterization/NN
of/IN
these/DT
cells/NNS
should/MD
identify/VB
factors/NNS
involved/VBN
in/IN
the/DT
growth/NN
,/,
terminal/JJ
differentiation/NN
and/CC
activation/NN
of/IN
osteoclasts/NNS
./.